5W84
CRYSTAL STRUCTURE OF IRAK-4 WITH A 4,6-DIAMINONICOTINAMIDE INHIBITOR (COMPOUND NUMBER 4)
Summary for 5W84
Entry DOI | 10.2210/pdb5w84/pdb |
Related | 5w85 5w86 |
Descriptor | Interleukin-1 receptor-associated kinase 4, 4-(benzylamino)-6-[(2-oxo-2,3-dihydro-1H-indol-5-yl)amino]pyridine-3-carboxamide (3 entities in total) |
Functional Keywords | serine/threonine protein kinase, transferase, transferase-transferase inhibitor complex, transferase/transferase inhibitor |
Biological source | Homo sapiens (Human) |
Cellular location | Cytoplasm : Q9NWZ3 |
Total number of polymer chains | 2 |
Total formula weight | 69291.95 |
Authors | Sack, J.S. (deposition date: 2017-06-21, release date: 2017-10-11, Last modification date: 2017-10-25) |
Primary citation | Bhide, R.S.,Keon, A.,Weigelt, C.,Sack, J.S.,Schmidt, R.J.,Lin, S.,Xiao, H.Y.,Spergel, S.H.,Kempson, J.,Pitts, W.J.,Carman, J.,Poss, M.A. Discovery and structure-based design of 4,6-diaminonicotinamides as potent and selective IRAK4 inhibitors. Bioorg. Med. Chem. Lett., 27:4908-4913, 2017 Cited by PubMed: 28947151DOI: 10.1016/j.bmcl.2017.09.029 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.9 Å) |
Structure validation
Download full validation report